JournalLicensing

Medical device technologies available for licensing in India

Medical device technology transfer in India: where ICMR, SCTIMST and the IITs offer devices for licensing, their terms, and the CDSCO licences you still need.

By Sahil Sheikh, Regd. Patent & Trademark Agent, cRTTP 7 min read

Part of the guide Licensing technology from Indian institutions: the complete guide for companies

Short answer

Indian companies can license medical device technologies from ICMR institutes through Expression of Interest calls on the Patent Mitra portal, from SCTIMST Thiruvananthapuram's Biomedical Technology Wing, and from IIT technology transfer offices. ICMR's 2024 guidelines set a 2% royalty on net sales, non-exclusive by default. The licensee still needs its own CDSCO or state manufacturing licence.

Indian public institutes have spent years building local alternatives to imported medical devices: heart valves, stents, contrast injectors, wound dressings, diagnostic apparatus. Many of these are offered to industry under licence. For a device company or an MSME moving into medtech, licensing one can save years of early R&D.

This guide covers where the technologies sit, what the published terms look like, and the regulatory steps that remain with you after you sign.

Which Indian institutions license medical device technologies?

Three sources publish device technologies and the process to license them.

Source How technologies are offered Published terms
ICMR institutes One Expression of Interest (EoI) per technology, on the Medical Innovation Patent Mitra portal 2% royalty on net sales; non-exclusive by default (2024 guidelines)
SCTIMST, Biomedical Technology Wing, Thiruvananthapuram EoI calls listing several technologies; enquiries to the Technology Business Division Upfront fee plus annual royalty, varying by product; exclusive or non-exclusive
IITs Technology transfer office reviews each request; IIT Kanpur routes it through SIIC Set in the agreement; IIT Kanpur's template leaves the royalty and royalty-free period blank

Other institutes, including AIIMS campuses, NITs and central universities, also hold device patents. They publish less, so expect to ask their IPR cells directly.

What has ICMR offered recently?

ICMR advertises one technology at a time. Two EoIs published on 4 August 2026, with a last date of 25 August 2026, show the format.

  • A portable apparatus for separation of biological biomolecules, developed at ICMR-NIVCR and described in the EoI as a medical device. It was at TRL 3 to 4: proof of concept shown in the lab, with field studies still needed. The patent application (No. 202211008794, filed 19 February 2022) was awaiting examination. The EoI allowed exclusive or non-exclusive licensing and stated a 2% royalty on net sales.
  • A microcontroller-based device for feeding mosquitoes in the laboratory, also from ICMR-NIVCR, at TRL 4 and offered non-exclusively. It is lab equipment for vector research rather than a patient device. Still, it shows how ICMR describes stage and IP in each call.

ICMR also licenses technologies in batches at events. At India MedTech Expo 2025, on 4 September 2025, it licensed nine technologies to industry partners under the Patent Mitra initiative, according to All India Radio News.

The pre-qualification criteria in these EoIs are strict. They ask for an Indian legal entity with more than 51% Indian promoter stake, manufacturing or R&D experience in the last three years, no overall loss in three years for commercial firms, a manufacturing unit in India, GMP or ISO certification and a functional laboratory. MSMEs and startups are assessed under the relevant Government of India guidelines. Our step-by-step guide to licensing from ICMR walks through the documents.

What does SCTIMST offer?

The Biomedical Technology Wing of the Sree Chitra Tirunal Institute for Medical Sciences and Technology (SCTIMST) has a long record of device transfers. An EoI on its website, with a last date of 31 December 2023, listed four technologies:

  • a bioprosthetic heart valve based on bovine pericardium;
  • a TiN-coated coronary stent system;
  • an automatic contrast injector;
  • an automated patient trolley, the e-Drive.

The call said these were at stages from proof of concept to pre-clinical or clinical evaluation, and that terms would combine an upfront lump sum with annual royalties, varying by product, on an exclusive or non-exclusive basis.

A SCTIMST press release from June 2024 then announced transfers: the automatic contrast injector to Cyrix Healthcare, Kochi; the e-Drive trolley to Quasys Software & Consultancy; bioactive HA-TCP ceramic beads for drug delivery to Onyx Medicals, Meerut; and a GelMA bioink to Scire Science, Kochi.

That 2023 list is a past call, and some of those technologies are now licensed. Contact the Technology Business Division (tbd@sctimst.ac.in) for what is open today.

Licensing a device from a public institute

Your EoILicence signed
Find the callPatent Mitra, SCTIMST, IIT office
Pre-qualifyEntity, facility, GMP or ISO
ShortlistConcept note and presentation
AgreementFee, royalty, exclusivity

And the IITs?

Most IITs list their patents and invite companies to ask. At IIT Kanpur, a company sends a formal request to the SIDBI Innovation and Incubation Centre, which acts as the institute's technology transfer office. The Technology Transfer and Equity Management Advisory Committee reviews it, and an approved licence follows the terms of an MoU.

IIT Kanpur's published MoU template offers the IP "as is", gives no warranty of non-infringement, and makes the licensee indemnify the institute. Royalty, the royalty-free period and the sublicensing share are left blank for negotiation. Our posts on licensing from an IIT and on warranties and indemnity in a university licence explain how to negotiate those terms.

What regulatory licences do you still need?

The technology licence gives you rights to the IP and know-how. It does not let you make or sell a device. That comes from the Medical Devices Rules, 2017, administered by CDSCO and state authorities. ICMR's 2024 guidelines say plainly that obtaining certifications and approvals is the licensee's job.

Step Application form Licence or permission
Test licence, to make units for testing or clinical investigation MD-12 MD-13
Clinical investigation MD-22 MD-23
Manufacturing licence, Class A or B (State Licensing Authority) MD-3 MD-5
Manufacturing licence, Class C or D (Central Licensing Authority) MD-7 MD-9

CDSCO's overview notes that clinical investigation is not mandatory for Class A devices, and that some non-sterile, non-measuring Class A devices are exempt from licensing. The class of the device therefore shapes both your cost and your timeline. Our guide to TRL for medical devices maps these steps onto readiness levels.

After signing: from licence to sale

1
Confirm risk classClass A, B, C or D
2
Test licenceMD-12 application, MD-13 licence
3
Clinical investigationMD-22 application, MD-23 permission
4
Manufacturing licenceMD-5 from the state, or MD-9 from CDSCO

A worked example in rupees

The figures below are an illustration.

A Hyderabad MSME licenses a diagnostic apparatus from an ICMR institute at the 2% royalty in the 2024 guidelines. It spends two years on design transfer, testing and the manufacturing licence. In its first full year of sales it sells 1,500 units at ₹10,000 each, for net sales of ₹1,50,00,000.

  • Royalty to ICMR at 2%: ₹3,00,000 for the year.
  • If sales grow to ₹4,00,00,000 by year five, royalty that year is ₹8,00,000.
  • Under the guidelines, the royalty stops 10 years after commercialisation.

Add any upfront fee set in the agreement, GST on the royalty, and tax deducted at source. Our post on GST and TDS on royalty covers both. Also watch the timing: ICMR's 2024 guidelines allow march-in rights if the product is not commercialised within two years (counted from completion of the project, or from licensing, depending on the clause).

What should you check before you sign?

  1. Stage, honestly assessed. A TRL 3 to 4 device can need years of work and clinical evidence before sale. Budget for it.
  2. Patent status on IP India. A pending application may still narrow or fail in examination. See our patent due diligence checklist.
  3. Exclusivity. ICMR's default is non-exclusive, so a competitor may hold the same licence. If you need exclusivity, ask early; ICMR allows it only in exceptional circumstances after committee review.
  4. Know-how and training. A device patent rarely contains everything you need to manufacture. Ask what drawings, test methods and support come with the licence.
  5. Regulatory class and route. Confirm the class before you commit to a budget.

In my view, the strongest candidates for an MSME are devices at TRL 5 or above in Class A or B, where the regulatory path is shorter and the state authority issues the manufacturing licence. A high-risk implant at TRL 3 is a better fit for a company with a clinical and regulatory team already in place. The published lists change often, and some calls close within three weeks, so check each institute's site regularly rather than relying on any list, including this one.

To compare device technologies across institutions before writing to each IPR cell, Zernyx Hub has mapped patents from universities across India, with AI business insight on each, including its commercial applications.

Common questions

Where can a company find medical device technologies to license in India?

Three good starting points are ICMR's Expression of Interest calls, which run through the Medical Innovation Patent Mitra portal; the Technology Business Division of SCTIMST's Biomedical Technology Wing in Thiruvananthapuram; and IIT technology transfer offices, such as SIIC at IIT Kanpur.

What royalty does ICMR charge on a licensed medical device?

ICMR's 2024 Guidelines for Technology Development Collaboration set a royalty of 2% of net sales for licensing, with a sunset of 10 years from commercialisation. ICMR's August 2026 device EoIs state the same 2%. Confirm the rate in the EoI for the technology you want.

Does licensing a device from ICMR or an IIT give me approval to sell it?

No. Regulatory approval stays with the licensee. Under the Medical Devices Rules, 2017, a Class A or B device needs a manufacturing licence from the State Licensing Authority (some non-sterile, non-measuring Class A devices are exempt), and a Class C or D device needs one from the Central Licensing Authority.

At what readiness level are public-institute medical devices offered?

It varies widely. One ICMR device in an August 2026 EoI was at TRL 3 to 4, with proof of concept in the lab and field studies still needed. SCTIMST says its offered technologies range from proof of concept to pre-clinical or clinical evaluation.

Sahil Sheikh
About the author

Sahil Sheikh, Regd. Patent & Trademark Agent, cRTTP

Chief IP & Technology Officer, Zernyx Innovations

Connect on LinkedIn

Find a technology you can own.

Search patented technologies from Indian universities and labs, check their readiness and license the right one on Zernyx Hub.

Explore Zernyx Hub

Keep reading

Looking for something else?